These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27698012)

  • 1. Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling.
    Kölm R; Schaller M; Roumenina LT; Niemiec I; Kremer Hovinga JA; Khanicheh E; Kaufmann BA; Hopfer H; Trendelenburg M
    J Immunol; 2016 Nov; 197(9):3669-3679. PubMed ID: 27698012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C1q Enhances Primary Hemostasis.
    Donat C; Kölm R; Csorba K; Tuncer E; Tsakiris DA; Trendelenburg M
    Front Immunol; 2020; 11():1522. PubMed ID: 32765527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.
    Donat C; Thanei S; Trendelenburg M
    Front Immunol; 2019; 10():2712. PubMed ID: 31824501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
    Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M
    J Immunol; 2009 Dec; 183(12):8225-31. PubMed ID: 20007586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of von Willebrand factor in haemostasis and thrombosis.
    Reininger AJ
    Haemophilia; 2008 Nov; 14 Suppl 5():11-26. PubMed ID: 18786007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
    Lood C; Tydén H; Gullstrand B; Sturfelt G; Jönsen A; Truedsson L; Bengtsson AA
    PLoS One; 2014; 9(6):e99386. PubMed ID: 24922069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis.
    Peerschke EI; Ghebrehiwet B
    Immunobiology; 1998 Aug; 199(2):239-49. PubMed ID: 9777409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery.
    Schulz K; Donat C; Punjabi M; Glatz K; Kaufmann B; Trendelenburg M
    Front Immunol; 2023; 14():1265387. PubMed ID: 38155969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S; Vanhecke D; Trendelenburg M
    Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.
    Thanei S; Trendelenburg M
    J Leukoc Biol; 2017 Feb; 101(2):481-491. PubMed ID: 27630215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests for circulating immune complexes.
    Wener MH
    Methods Mol Biol; 2014; 1134():47-57. PubMed ID: 24497353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits.
    Uwatoko S; Gauthier VJ; Mannik M
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):268-73. PubMed ID: 1914260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coating conditions matter to collagen matrix formation regarding von Willebrand factor and platelet binding.
    Mendelboum Raviv S; Szekeres-Csiki K; Jenei A; Nagy J; Shenkman B; Savion N; Harsfalvi J
    Thromb Res; 2012 Apr; 129(4):e29-35. PubMed ID: 22056526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.